Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC-Reference-Cited by-同舟云学术

Stereotactic radiosurgery with whole brain radiotherapy combined with bevacizumab in the treatment of brain metastases from NSCLC

Published:2021-09-24 Issue: Volume: Page:1-8
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

Li Lu¹,Feng Mei¹,Xu Peng¹,Wu Yi Lin²,Yin Jun¹,Huang Yecai¹,Tan Ming Yu¹,Jinyi Lang¹

Affiliation:

1. Sichuan Cancer Hospital & Institute, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

2. School of Clinical Medicine, Chengdu Medical College, Chengdu, China

Publisher

Informa UK Limited

Subject

General Medicine,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/00207454.2021.1916490

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Update on systemic therapy of advanced non-small-cell lung cancer

3. Therapeutic management of brain metastasis

4. Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis

5. Neuroimaging and quality-of-life outcomes in patients with brain metastasis and peritumoral edema who undergo Gamma Knife surgery

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficiency of radiotherapy plus Anlotinib in alleviating edema and increasing radiosensitivity in symptomatic brain metastasis patients: A retrospective study;2024-04-05

2. Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy;Clinical and Translational Oncology;2024-03-13

3. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy;Thoracic Cancer;2023-09-17

4. RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis;Frontiers in Oncology;2022-11-28

5. Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases;Neuro-Oncology Advances;2021-11-01